Severe rhabdomyolysis in an infant with Multisystem Inflammatory Syndrome Related to COVID-19 (MIS-C)

Authors

  • María del Carmen Valdivia-Tapia Servicio de Cuidados Intensivos Pediátricos, Hospital de Emergencias Pediátricas, Lima, Perú.
  • Alicia Marilú Vargas-Vega Servicio de Cuidados Intensivos Pediátricos, Hospital de Emergencias Pediátricas, Lima, Perú.
  • Grimaldo Ramirez-Cortez Servicio de Cuidados Intensivos Pediátricos, Hospital de Emergencias Pediátricas, Lima, Perú.
  • Nilton Yhuri Carreazo Servicio de Cuidados Intensivos Pediátricos, Hospital de Emergencias Pediátricas, Lima, Perú.

DOI:

https://doi.org/10.35434/rcmhnaaa.2022.154.1624

Keywords:

Rhabdomyolysis, SARS-CoV-2, Multisystem Inflammatory Syndrome in Children (MIS-C), Renal Insufficiency

Abstract

A case of severe rhabdomyolysis associated with multisystem inflammatory syndrome related to COVID-19 (MIS-C) is presented in a one-year 10-month-old boy who presented digestive symptoms, myalgia, weakness, fever, and dark urine. COVID-19 IgM (-) IgG (+) serological test, COVID-19 PCR negative. Initial creatine kinase (CK) presented non-dosable values, with the highest reported level being 517,600 U/L. The creatinine value remained normal throughout the hospitalization. He received human immunoglobulin 2 g/Kg, Methylprednisolone 10 mg/Kg/d, and acetylsalicylic acid to manage MIS-C. Aggressive hydration and urine alkalinization were provided to manage rhabdomyolysis. Positive evolution with discharge after ten days. Few reported cases of rhabdomyolysis are associated with MIS-C and none with such high CK values. Based on the possible complications, performing CK dosing in all patients with MIS-C is suggested routinely.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

María del Carmen Valdivia-Tapia , Servicio de Cuidados Intensivos Pediátricos, Hospital de Emergencias Pediátricas, Lima, Perú.

1. Médico Intensivista Pediatra.

Alicia Marilú Vargas-Vega, Servicio de Cuidados Intensivos Pediátricos, Hospital de Emergencias Pediátricas, Lima, Perú.

  1. Médico Intensivista Pediatra.

Grimaldo Ramirez-Cortez, Servicio de Cuidados Intensivos Pediátricos, Hospital de Emergencias Pediátricas, Lima, Perú.

  1. Médico Pediatra.

Nilton Yhuri Carreazo, Servicio de Cuidados Intensivos Pediátricos, Hospital de Emergencias Pediátricas, Lima, Perú.

  1. Médico Pediatra.

References

Szugye HS. Pediatric Rhabdomyolysis. Pediatr Rev. 2020;41(6):265-275. doi: 10.1542/pir.2018-0300.

Yao Z, Yuan P, Hong S, Li M, Jiang L. Clinical Features of Acute Rhabdomyolysis in 55 Pediatric Patients. Front Pediatr. 2020;8:539. doi: 10.3389/fped.2020.00539.

Armanpoor P, Armanpoor P. Pediatric COVID-19 Associated Rhabdomyolysis. J Pediatr Res. 2021;8:(3)363-366. doi: 10.4274/jpr.galenos.2021.27790.

You J, Lee J, Park YS, Lee JH. Virus-associated Rhabdomyolysis in Children. Childhood Kidney Diseases. 2017;21(2): 89–93. doi: 10.3339/jkspn.2017.21.2.89.

Park Y, Song JY, Kim SY, Kim SH. Clinical Characteristics of Rhabdomyolysis in Children: Single Center Experience. Childhood Kidney Diseases 2018;22(2):52–57. doi: 10.3339/jkspn.2018.22.2.52.

Babu MS, Ashoka HG, Adusumilli A. Rhabdomyolysis in Hepatitis A: Uncommon complication of a common infection. APIK J Int Med 2022;11(1):63-64. doi: 10.4103/ajim.ajim_98_20.

Ann SH, An GH, Lee SY, Oak JH, Moon HI, Moon SK, et al. A case of rhabdomyolysis during hospitalization for acute hepatitis A. Korean J Hepatol. 2009;15(1):85-9. doi: 10.3350/kjhep.2009.15.1.85.

Gefen AM, Palumbo N, Nathan SK, Singer PS, Castellanos-Reyes LJ, Sethna CB. Pediatric COVID-19-associated rhabdomyolysis: a case report. Pediatr Nephrol. 2020;35(8):1517-1520. doi: 10.1007/s00467-020-04617-0.

Fabi M, Guida F, Pierantoni L, Greco L, di Luca D, Lanari M. Severe Rhabdomyolysis in a Child with Multisystem Inflammatory Syndrome: An Autoimmune Mechanism? Pediatr Neurol 2021;124: 11–12. doi: 10.1016/j.pediatrneurol.2021.07.015

Cassim F, Soni AJ, Murphy S. Severe acute inflammatory myositis and rhabdomyolysis in paediatric SARS-CoV-2-associated MIS-C (multisystem inflammatory syndrome in children). BMJ Case Rep 2021 Aug 9; 14(8): e243112. DOI: 10.1136/bcr-2021-243112

García-Salido A, Antón J, Martínez-Pajares JD, Garcia Giralt G, Gómez Cortés B, Tagarro A. Grupo de trabajo de la Asociación Española de Pediatría para el Síndrome Inflamatorio Multisistémico Pediátrico vinculado a SARS-CoV-2. Documento español de consenso sobre diagnóstico, estabilización y tratamiento del síndrome inflamatorio multisistémico pediátrico vinculado a SARS-CoV-2 (SIM-PedS). An Pediatr (Barc). 2021;94(2):116.e1-116.e11. doi: 10.1016/j.anpedi.2020.09.005.

Dolhnikoff M, Ferreira Ferranti J, de Almeida Monteiro RA, Duarte-Neto AN, Soares Gomes-Gouvêa M, Viu Degaspare N, et al. SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome. The Lancet Child & Adolescent Health. 2020;4(10):790–794. doi: 10.1016/S2352-4642(20)30257-1.

Consiglio CR, Cotugno N, Sardh F, Pou C, Amodio D, Rodriguez L, et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell 2020;183(4): 968-981.e7. doi: 10.1016/j.cell.2020.09.016.

Somagutta MR, Pagad S, Sridharan S, Nanthakumaran S, Arnold AA, May V, Malik BH. Role of Bicarbonates and Mannitol in Rhabdomyolysis: A Comprehensive Review. Cureus. 2020;12(8): e9742. doi: 10.7759/cureus.9742.

Published

2023-02-20

How to Cite

1.
Valdivia-Tapia M del C, Vargas-Vega AM, Ramirez-Cortez G, Yhuri Carreazo N. Severe rhabdomyolysis in an infant with Multisystem Inflammatory Syndrome Related to COVID-19 (MIS-C). Rev. Cuerpo Med. HNAAA [Internet]. 2023 Feb. 20 [cited 2024 Nov. 21];15(4):630-3. Available from: http://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1624